UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 103

Sortiert nach

Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036

European journal of cancer (1990), 2021-07, Vol.152, p.18-25

2021

Volltextzugriff (PDF)

Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

International journal of molecular sciences, 2020-12, Vol.21 (23), p.9300

2020

Volltextzugriff (PDF)

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?

Cancers, 2020-11, Vol.12 (12), p.3538

2020

Volltextzugriff (PDF)

The many unanswered questions related to the German skin cancer screening programme

European journal of cancer (1990), 2016-09, Vol.64, p.83-88

2016

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2010-01, Vol.46 (2), p.270-283

2010

Volltextzugriff (PDF)

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

European journal of cancer (1990), 2019-07, Vol.116, p.207-215

2019

Volltextzugriff (PDF)

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Cell death & disease, 2020-07, Vol.11 (7), p.581, Article 581

2020

Volltextzugriff (PDF)

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma

Cancers, 2024-01, Vol.16 (3), p.606

2024

Volltextzugriff (PDF)

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma

Cancers, 2020-02, Vol.12 (3), p.540

2020

Volltextzugriff (PDF)

The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review

Radiologia medica, 2022-07, Vol.127 (7), p.773-783

2022

Volltextzugriff (PDF)

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients

Cancers, 2020-09, Vol.12 (9), p.2359

2020

Volltextzugriff (PDF)

Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective Study

Cancers, 2021-05, Vol.13 (11), p.2642

2021

Volltextzugriff (PDF)

6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells

Cellular physiology and biochemistry, 2018-11, Vol.51 (2), p.543-556

2018

Volltextzugriff (PDF)

Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?

Neuroradiology, 2019-07, Vol.61 (7), p.775-782

2019

Volltextzugriff (PDF)

Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion

Cancers, 2020-08, Vol.12 (8), p.2328

2020

Volltextzugriff (PDF)

Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

Cancers, 2020-04, Vol.12 (5), p.1101

2020

Volltextzugriff (PDF)

The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022

Journal of translational medicine, 2023-04, Vol.21 (1), p.265-265, Article 265

2023

Volltextzugriff (PDF)

Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy

Cancers, 2021-11, Vol.13 (21), p.5411

2021

Volltextzugriff (PDF)

Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV Melanoma

Cancers, 2020-04, Vol.12 (4), p.1027

2020

Volltextzugriff (PDF)

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade

Frontiers in immunology, 2022-07, Vol.13, p.906352-906352

2022

Volltextzugriff (PDF)

Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study

European radiology, 2016-06, Vol.26 (6), p.1826-1834

2016

Volltextzugriff (PDF)

Diagnostic Performance of a Support Vector Machine for Dermatofluoroscopic Melanoma Recognition: The Results of the Retrospective Clinical Study on 214 Pigmented Skin Lesions

Diagnostics (Basel), 2019-08, Vol.9 (3), p.103

2019

Volltextzugriff (PDF)

Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma

Frontiers in oncology, 2021-03, Vol.11, p.643156

2021

Volltextzugriff (PDF)

Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1780-1787

2010

Volltextzugriff (PDF)

A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib

EBioMedicine, 2016-06, Vol.8 (C), p.132-149

2016

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

ThemaDermatology

ThemaPrognosis

KollektionIngenta.com

KollektionIngentaConnect

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(102)
Buchkapitel
(1)

Sprache

Englisch
(103)
Japanisch
(10)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036

Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?

The many unanswered questions related to the German skin cancer screening programme

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma

The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients

Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective Study

6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells

Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?

Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion

Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022

Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy

Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV Melanoma

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade

Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study

Diagnostic Performance of a Support Vector Machine for Dermatofluoroscopic Melanoma Recognition: The Results of the Retrospective Clinical Study on 214 Pigmented Skin Lesions

Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma

Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib

Aktive Filter

Suchergebnisse filtern